Publication: 4774

Publication: 4774

AFT-50A EndoMAP: A phase IB/II multicohort study of targeted agents and Atezolizumab (Atezo) for patients (pts) with recurrent or persistent endometrial cancer (EC).

Google Scholar

Citation:

Meeting Instance:: SGO 2026
Year:: 2026
Type:: Abstract
Sub type:
Funding:: AFT
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: GU
Sec. Committees:

Pharmas:: Genentech
Grants:

Corr. Author:
Authors:: Evelyn Cantillo Tyler Zemla John W. Moroney Edwin A. Alvarez Yvonne G. Lin Joyce Liu Angeles Alvarez Secord Andrew B. Nixon Sumithra Mandrekar Ursula Matulonis David Kozono Brian M. Slomovitz

Networks:: CA824, FL036, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NC010, NY018

Study: AFT-50
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 1/2

Keywords: